F Brock

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis

Ronald van Vollenhoven, Mikkel Østergaard, Marjatta Leirisalo‐Repo et al. · Annals of the Rheumatic Diseases · 2015 · 134 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Inherited erythromelalgia due to mutations in<i>SCN9A:</i>natural history, clinical phenotype and somatosensory profile

Aoibhinn McDonnell, Betsy R. Schulman, Zahid Ali et al. · Brain · 2016 · 93 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical Trials

Bernard Combe, Frank Behrens, Neil McHugh et al. · The Journal of Rheumatology · 2016 · 37 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept

C.E.M. Griffiths, Wolfram Sterry, F Brock et al. · British Journal of Dermatology · 2014 · 24 citations

Medicine, Dermatology, Pharmacotherapy +11

Long‐term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo‐controlled studies

Andrew Blauvelt, C. Paul, P.C.M. van de Kerkhof et al. · British Journal of Dermatology · 2020 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9